Tech stocks account for nearly 40% of the S&P 500, prompting diversification into defensive healthcare names like Johnson & Johnson.
Technology stocks represent nearly 40% of the S&P 500’s value, more than triple the weighting of the next-largest sector. This heavy concentration has raised concerns among investors about potential volatility in the sector.
Johnson & Johnson, a Dividend King with over 50 consecutive years of dividend increases, offers exposure to healthcare, a resilient industry less prone to economic cycles. The company’s dual focus on pharmaceuticals and medical devices relies on sustained innovation to remain competitive.
The shift reflects a broader strategy to reduce sector-specific risk while maintaining growth potential in a historically stable industry.